Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Russia Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20082
20097
20101
20114
20123
20131
20142
20161
20171
20183
20191
20207
20212
20223
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GlaxoSmithKline4
I.M. Sechenov First Moscow State Medical University4
Takeda3
Bayer2
Eurasian Association of Therapists2
National Medical Research Center for Therapy and Preventive Medicine2
Ryazan State Medical University2
Tomsk National Research Medical Center of the Russian Academy of Sciences2
AO GENERIUM1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases44
Coronary Disease7
Heart Diseases7
Acute Coronary Syndrome6
Atherosclerosis6
Heart Failure6
Hypertension6
Vascular Diseases6
Coronary Artery Disease5
Diabetes Mellitus, Type 24

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.